Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Game Changer for the Human Genome Sector?
Minyanville
Friday, August 31, 2012 - 1:04pm
tags:
stem cells, ALS, Neuralstem, Pfizer, GSK, JNJ, GE Healthcare, Arthersys
FDA approves Ironwood, Forest Labs bowel drug
Yahoo/AP
Friday, August 31, 2012 - 12:58pm
tags:
FDA, Ironwood, Forest Labs, Linzess
Sarepta rallies for second consecutive day
Marketwatch
Friday, August 31, 2012 - 12:55pm
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
5 Pharmaceutical Companies With EMA Catalysts During The Next 3-12 Months
Seeking Alpha
Friday, August 31, 2012 - 12:51pm
tags:
Affymax, Arena Pharmaceuticals, Avanir, Curis, Dendreon
Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Yahoo/AP
Friday, August 31, 2012 - 12:34pm
tags:
Pfizer, immune therapy, VLST, CP-870, 893
Generics Will Drive Mylan Higher By 2013
Seeking Alpha
Friday, August 31, 2012 - 12:33pm
tags:
Mylan, generics, Bristol-Myers Squibb, Merck, Pfizer, Teva Pharmaceuticals
J&J Will Pay $181 Million To Settle Risperdal Ad Claims
Bloomberg
Friday, August 31, 2012 - 12:29pm
tags:
Risperdal, JNJ, settlements, advertising
Pfizer Loses Bid To Dismiss Fen-Phen Lung Ailment Suits
Bloomberg
Friday, August 31, 2012 - 12:28pm
tags:
Pfizer, Fen-Phen
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
Friday, August 31, 2012 - 12:27pm
tags:
tivantinib, Arqule, lung cancer, Tarceva, Roche, Astellas
Zalicus: Ready To Rebound
Seeking Alpha
Friday, August 31, 2012 - 12:24pm
tags:
Zalicus, Exalgo, Z160, Synavive, Prednisporin, Z944
FDA warns against use of Pfizer's Revatio in children
Reuters
Friday, August 31, 2012 - 12:20pm
tags:
FDA, Pfizer, Revatio, PAH, pulmonary arterial hypertension
Arena And Vivus Set To Dominate The Obesity Drug Market
Seeking Alpha
Thursday, August 30, 2012 - 9:58am
tags:
Arena, Vivus, obesity, Belviq, Qsymia
Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
Yahoo
Thursday, August 30, 2012 - 9:57am
tags:
Teva Pharmaceuticals, FDA, Tbo-filgrastim, neutropenia
Novartis Begs Vets To Stick With Its Animal Meds
Pharmalot
Thursday, August 30, 2012 - 9:52am
tags:
Novartis, animal health
4 Cash Loaded Biotech Stocks With Little Debt
Seeking Alpha
Thursday, August 30, 2012 - 9:48am
tags:
Obagi Medical Products, Cyclacel, Vanda, 3SBio
Exelixis Provides Update on ODAC Panel for Cabozantinib
Yahoo
Thursday, August 30, 2012 - 9:46am
tags:
Exelixis, cabozantinib, medullary thyroid cancer
Charles River Labs buys microbial identification testing company Accugenix for $17 million
Yahoo/AP
Thursday, August 30, 2012 - 9:42am
tags:
Charles River Laboratories, M&A, Accugenix
Sequenom Expands Its International Reach
Motley Fool
Thursday, August 30, 2012 - 9:42am
tags:
Sequenom, Maternit21 Plus
POZEN's PA32540 shows posiive results in a Phase 1 study
Yahoo/Fly on the Wall
Thursday, August 30, 2012 - 9:41am
tags:
Pozen, PA32540
Showtime Is Drawing Near for This Drug: Dynavax's Heplisav
Motley Fool
Thursday, August 30, 2012 - 9:39am
tags:
Heplisav, Dynavax, vaccines, hepatitis B

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.